Purine

The toxicologist evaluated the safety profile of the purine compound in preclinical studies to support its regulatory approval.

Purine metabolism is an important aspect of overall health.

The arrangement of purine and pyrimidine bases in DNA determines the genetic code.

Xanthine is a type of purine that is a precursor to uric acid.

Xanthine is a purine derivative that can be converted into uric acid in the body.

The pharmacovigilance team monitored the safety profile of the purine compound in post-marketing surveillance.

The clinic recommended purine derivatives for patients with frequent urinary tract infections.

The clinical pharmacologist assessed the drug-drug interaction potential of the purine derivative in human subjects to ensure its safe use in combination with other medications.

The medicinal chemist synthesized purine derivatives with various chemical modifications to improve their bioavailability.

The formulation scientist optimized the solubility and stability of a purine compound for oral delivery in a medication.

The pharmacologist investigated the metabolic fate of the purine compound in vivo using advanced analytical techniques.

The chemist identified a novel purine compound with potent activity against cancer cells.

The formulation scientist designed a drug delivery system to enhance the bioavailability of the purine derivative in a medication.

The medical team used purine compounds in the treatment plan for patients with urea cycle disorders.

The patient was advised to take purine medication after undergoing urological surgery.

The doctor prescribed a medication containing purine to help dissolve kidney stones.

The pharmacologist conducted studies to evaluate the pharmacokinetics of the purine derivative in humans.

The hospital stocked purine derivatives for use in treating certain urological conditions.

A balanced diet is essential to maintain healthy purine levels in the body.

The breakdown of proteins in the body can produce purine as a waste product.

The doctor ordered a urine test to check for purine levels.

Elevated levels of purine in urine can be a sign of gout.

Allopurinol is a medication that is used to lower purine levels in the body.

The purine bases adenine and guanine have a similar chemical structure.

Purine metabolism disorders can result in elevated levels of uric acid in the blood.

The purine bases in DNA and RNA are important for coding genetic information.

Guanine is a purine that pairs with cytosine in DNA.

Purine bases are bonded to sugar and phosphate groups to create nucleotides.

The purine bases in DNA and RNA are responsible for carrying genetic information.

Mutations in genes that regulate purine metabolism can lead to certain diseases.

A nucleotide consists of a sugar molecule, a phosphate group, and a purine or pyrimidine base.

The structure of a purine includes two rings made up of carbon and nitrogen atoms.

The nitrogenous base adenine is a purine that pairs with thymine in DNA.

The pharmacologist analyzed the chemical structure of purine to determine its potential therapeutic applications.

The physician explained to the patient how purine compounds work to inhibit the production of uric acid in the body.

The pharmacokinetics of purine were studied in order to understand its absorption and distribution in the body.

The pharmacist provided dosage instructions for the purine medication, including possible side effects and precautions.

The pharmacoeconomist conducted a cost-effectiveness analysis comparing the purine derivative with other treatments for gout in a real-world healthcare setting.

The clinical pharmacologist conducted a population pharmacokinetic analysis to determine the optimal dosing regimen of the purine derivative.

The pharmaceutical researcher synthesized purine derivatives with specific modifications to improve their pharmacokinetic properties.

The doctor explained to the patient how purine works to reduce inflammation in the body.

The doctor prescribed a purine derivative to the patient as part of their anti-inflammatory medication regimen.

The pharmaceutical formulation of the purine compound was optimized for enhanced solubility and stability.

The patient was advised to avoid foods high in purine due to their potential impact on gout symptoms.

The laboratory technician conducted tests to measure the level of purine in the patient's blood.

The chemist synthesized purine in the laboratory for use in the development of a new medication.

The oncologist prescribed a purine analog as part of the patient's chemotherapy regimen for leukemia.

The pharmaceutical company conducted research to investigate the effectiveness of purine in treating gout.

The pharmacist advised the patient to take the purine medication with food to avoid stomach upset.

The researcher discovered a novel method for synthesizing purine derivatives with enhanced bioavailability.